@DonnaYoungDC @DrNancyM_CDC Here are the international recommendations for mobile apps for collecting AE reports. Hope V-SAFE will learn from our experience build these for 4 countries! https://t.co/TeiIjSdIMR
@PAallergy @CDCgov One-way info collecting apps for safety surveillance have loooow uptake. If that’s our active surveillance we will miss important signals
CDC surveillance plan for vaccine safety surveillance requires people to download an app (V-SAFE) We’ve built 4 of these, and patients use them a lot less than you’d think because of lack of feedback https://t.co/TeiIjSdIMR #VRBPAC
RT @YellowCardWM: Two open source papers arising from the WEB-RADR project are at https://t.co/ocIGZgqSLd https://t.co/QVzu94cwL7 https://t…
Two open source papers arising from the WEB-RADR project are at https://t.co/ocIGZgqSLd https://t.co/QVzu94cwL7 https://t.co/uoqJqKuFu9
RT @PVpapers: Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Infor…
Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR https://t.co/7tkw2GvFxI
RT @MagnusEkelo: The WEB-RADR app experience has been evaluated. Usage in the first European countries have been modest but is expected to…
The WEB-RADR app experience has been evaluated. Usage in the first European countries have been modest but is expected to rise over time. https://t.co/nyffiUY5pU https://t.co/25Vk3vuy0Y
RT @WEBRADR: .@IMI_JU @WEBRADR publication in #DrugSafety - Recommendations on the Use of Mobile Applications for the Collection and Commun…
RT @PVpapers: Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Infor…
RT @PVpapers: Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Infor…
Excellent overview of the @WEBRADR Adverse Event reporting app design for patients & HCPs.
Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR https://t.co/nd0APWlEQA
RT @WEBRADR: .@IMI_JU @WEBRADR publication in #DrugSafety - Recommendations on the Use of Mobile Applications for the Collection and Commun…
RT @nagumo_wr: excellent!!! https://t.co/snAwqkfUn5
excellent!!!
RT @WEBRADR: .@IMI_JU @WEBRADR publication in #DrugSafety - Recommendations on the Use of Mobile Applications for the Collection and Commun…
RT @WEBRADR: .@IMI_JU @WEBRADR publication in #DrugSafety - Recommendations on the Use of Mobile Applications for the Collection and Commun…
RT @WEBRADR: .@IMI_JU @WEBRADR publication in #DrugSafety - Recommendations on the Use of Mobile Applications for the Collection and Commun…
RT @asrowe: Congratulations to the team! https://t.co/SeiSK4vjcw
RT @WEBRADR: .@IMI_JU @WEBRADR publication in #DrugSafety - Recommendations on the Use of Mobile Applications for the Collection and Commun…
RT @WEBRADR: .@IMI_JU @WEBRADR publication in #DrugSafety - Recommendations on the Use of Mobile Applications for the Collection and Commun…
Congratulations to the team!
.@IMI_JU @WEBRADR publication in #DrugSafety - Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR https://t.co/z6VpzUZPlV